Medication for the treatment of diseases of the urinary tract :: Consumers survey results of for 3 quarter of 2010

Consumers survey results of for 3 quarter of 2010 in category

Gynecology, urology, nephrology / Medication for the treatment of diseases of the urinary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	4	Нефрофіт (Aim)	40.00%	5

2.	4	Гербіон (KRKA)	30.00%	3.75

2.	1	Уролесан (Arterium Corporation)	30.00%	3.75

4.	1	Канефрон Н (Bionorica)	20.00%	2.50

4.	5	Уронат Медивит (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	20.00%	2.50

4.	2	Цистон (Фірма ТК Комфорт)	20.00%	2.50

7.	~	Блемарен (Esparma)	10.00%	1.25

–.		Берёзы почки (Ternopharm)	0.00%	0

–.	4	Уро-гран (Національна гомеопатична спілка)	0.00%	0

–.	3	Фітолізин Плюс (Farmak)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2010, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.